[(4-[(S)-2-ACETYLAMINO-2-[(S)-1-(3-CARBAMOYL-4-CYCLOHEXYLMETHOXYPHENYL)-ETHYLCARBAMOYL]-ETHYL]-PHENYL)-PHOSPHONOMETHYL]-PHOSPHONIC-ACID
Compound with spectra: 1 NMR
![[(4-[(S)-2-ACETYLAMINO-2-[(S)-1-(3-CARBAMOYL-4-CYCLOHEXYLMETHOXYPHENYL)-ETHYLCARBAMOYL]-ETHYL]-PHENYL)-PHOSPHONOMETHYL]-PHOSPHONIC-ACID](/api/compound/3xnX173Vxkn.png?ph=true&h=300&w=458 "[(4-[(S)-2-ACETYLAMINO-2-[(S)-1-(3-CARBAMOYL-4-CYCLOHEXYLMETHOXYPHENYL)-ETHYLCARBAMOYL]-ETHYL]-PHENYL)-PHOSPHONOMETHYL]-PHOSPHONIC-ACID")
| SpectraBase Compound ID | 3xnX173Vxkn |
|---|---|
| InChI | InChI=1S/C28H39N3O10P2/c1-17(22-12-13-25(23(15-22)26(29)33)41-16-20-6-4-3-5-7-20)30-27(34)24(31-18(2)32)14-19-8-10-21(11-9-19)28(42(35,36)37)43(38,39)40/h8-13,15,17,20,24,28H,3-7,14,16H2,1-2H3,(H2,29,33)(H,30,34)(H,31,32)(H2,35,36,37)(H2,38,39,40)/t17-,24-/m0/s1 |
| InChIKey | UWNVRISRGNCNMT-XDHUDOTRSA-N |
| Mol Weight | 639.6 g/mol |
| Molecular Formula | C28H39N3O10P2 |
| Exact Mass | 639.211068 g/mol |
| Enantiomer InChIKey | UWNVRISRGNCNMT-MZNJEOGPSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO |
(4-[2-TERT.-BUTOXYCARBONYLAMINO-2-[1-(3-CARBAMOYL-4-CYCLOHEXYLMETHOXYPHENYL)-ETHYLCARBAMOYL]-ETHYL]-BENZYL)-PHOSPHONIC-ACID-DIETHYLESTER
2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[(4-methoxyphenyl)(phenyl)methyl]-3-phenylpropanamide
6-O-(L-TYROSILGLYCYLGLYCYL-L-PHENYLALANYL-L-LEUCYL)-ALPHA-D-MANNOPYRANOSE
N-[(4-bromophenyl)(phenyl)methyl]-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenylpropanamide
CRYPTOPHYCIN-C
(3S,6R,10R,13E,16S)-10-(3-chloro-4-methoxy-benzyl)-3-isobutyl-6-methyl-16-[(E,1R)-1-methyl-3-phenyl-allyl]-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-diquinone
5R,6S)-Cryptophycin C
18-(1-Phenylethylcarbamoyl)-2,13-dioxabicyclo[12.2.2]octadeca-1(17),14(18),15-triene-15-carboxylic acid, methyl ester
(E)-(3S,6R,10R,16S)-10-(3-Chloro-4-methoxy-benzyl)-6-methyl-16-((E)-(R)-1-methyl-3-phenyl-allyl)-3-propyl-1,4-dioxa-8,11-diaza-cyclohexadec-13-ene-2,5,9,12-tetraone
CHERIMOLACYCLOPEPTIDE_E;CYCLO-LEU-(1)-GLY-(2)-PRO-(3)-TYR-(OH)-(4)-PHE-(5)-GLY-(6);SYNTHETIC
| Title | Journal or Book | Year |
|---|---|---|
| X-ray Structure of Citrate Bound to Src SH2 Leads to a High-Affinity, Bone-Targeted Src SH2 Inhibitor | Journal of Medicinal Chemistry | 2001 |